ArticleHuman vaccines & immunotherapeutics2022

Resumption of active recommendation of the human papillomavirus vaccine in Japan and future challenges for the National Immunization Program.

Mugen UjiiePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.